CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 259 shares at $7.53 ($1,950)
- 4 Planned sale DesRosier Thomas sold 79 shares at $7.53 ($595)
- 4 Open-market sale Brady Kelly sold 59 shares at $7.53 ($444)
- 4 Planned sale Henn Matthew R sold 77 shares at $7.53 ($580)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 259 shares at $8.47 ($2,194)
- 4 Planned sale Young Teresa L. sold 75 shares at $8.47 ($635)
- 4 Planned sale DesRosier Thomas sold 78 shares at $8.47 ($661)
- 4 Planned sale Henn Matthew R sold 89 shares at $8.47 ($754)
- 4 Planned sale Young Teresa L. sold 1,042 shares at $17.30 ($18,027)
- 4 Planned sale Director sold 217 shares at $17.30 ($3,754)
- 4 Planned sale DesRosier Thomas sold 76 shares at $17.30 ($1,315)
Page 2 of 19 · 380 filings